BIOTEST AG ST O.N./ DE0005227201 /
04/10/2024 17:36:01 | Chg. 0.000 | Volume | Bid04/10/2024 | Ask04/10/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
41.600EUR | 0.00% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 2.42 bill.EUR | - | 12.75 |
Fundamentals
FY 2024 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | - EUR | - |
EPS Diluted: | - EUR | - |
Revenues per Share: | - EUR | - |
Book Value per Share: | - EUR | - |
Cash Flow per Share: | - EUR | - |
Dividend per Share: | - EUR | - |
Total | Units_-_Short | |
Revenues: | - EUR | - |
Net Income: | - EUR | - |
Operating Cash Flow: | - EUR | - |
Cash and Cash Equivalents: | - EUR | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 12.75 | - |
P/S Ratio: | 2.36 | - |
P/BV ratio: | 3.24 | - |
P/CF Ratio: | -597.97 | - |
PEG: | - | - |
Earnings Yield: | 7.84% | - |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 2.42 bill. EUR | - EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | 665,505.0460 EUR | - EUR |
Shares Outstanding: | 39.57 mill. |
Profitability
Gross Profit Margin: | - |
EBIT Margin: | - |
Net Profit Margin: | - |
Return on Equity: | - |
Return on Assets: | - |
Financial Strength
Liquidity I / Cash Ratio: | - |
Liquidity II / Quick Ratio: | - |
Liquidity III / Current Ratio: | - |
Debt / Equity Ratio: | - |
Dynam. Debt / Equity Ratio: | - |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - EUR |
Revenues / Employee: | - EUR |
Net Income / Employee: | - EUR |
Total Assets / Employee: | - EUR |
* Fiscal Year End: | - |
Accounting Standard: | - |
Currency: | EUR |